Glycosylated Biosimilars Market Report

China Glycosylated Biosimilars Industry Market Research Report 2023-2029

  • POSTDATE：Oct 08, 2023
  • PAGES：234
  • REPORT CODE：GMM1837539
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Glycosylated Biosimilars industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Stada Arzneimittel AG

    • Dr Reddy's Laboratories

    • Pfizer

    • Amgen

    • Mylan

    • Biocon

    • Sandoz

    • Samsung Biologics

    • Celltrion

    By Type:

    • EPO

    • mAb

    By Application:

    • Chronic Diseases

    • Autoimmune Diseases

    • Growth Hormone Deficiency

    • Oncology

    • Blood Disorders

    • Infectious Diseases

    • Other Diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Glycosylated Biosimilars Market Overview 2018-2029

    • 1.1 China Glycosylated Biosimilars Industry Development Overview

    • 1.2 China Glycosylated Biosimilars Industry Development History

    • 1.3 China Glycosylated Biosimilars Industry Market Size (2018-2029)

    • 1.4 China Glycosylated Biosimilars Market Analysis by Type from Production Side

      • 1.4.1 China Glycosylated Biosimilars Production Volume, Production Value and Growth Rate of EPO (2018-2029)

      • 1.4.2 China Glycosylated Biosimilars Production Volume, Production Value and Growth Rate of mAb (2018-2029)

    • 1.5 China Glycosylated Biosimilars Market Analysis by Application from Consumption End

      • 1.5.1 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Chronic Diseases (2018-2029)

      • 1.5.2 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

      • 1.5.3 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)

      • 1.5.4 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.5 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

      • 1.5.6 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.7 China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

    • 1.6 China Glycosylated Biosimilars Market Analysis by Region

      • 1.6.1 North China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    Chapter 2 China Glycosylated Biosimilars Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Glycosylated Biosimilars Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Glycosylated Biosimilars Market Status and Competition Analysis in 2023

      • 2.2.3 China Glycosylated Biosimilars Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Glycosylated Biosimilars Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Glycosylated Biosimilars Industry Development

    Chapter 3 Glycosylated BiosimilarsIndustry Chain Analysis

    • 3.1 Glycosylated Biosimilars Industry Chain

    • 3.2 Glycosylated Biosimilars Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Glycosylated Biosimilars Market

    • 3.3 Glycosylated Biosimilars Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Glycosylated Biosimilars Market

    Chapter 4 China Glycosylated Biosimilars Market, by Type

    • 4.1 China Glycosylated Biosimilars Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Glycosylated Biosimilars Total Production Volume and Growth Rate from Production Side

    • 4.5 China Glycosylated Biosimilars Production Volume and Growth Rate, by Type

      • 4.5.1 China Glycosylated Biosimilars Production Volume and Growth Rate of EPO

      • 4.5.2 China Glycosylated Biosimilars Production Volume and Growth Rate of mAb

    Chapter 5 China Glycosylated Biosimilars Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Glycosylated Biosimilars Total Market Size and Growth Rate from Consumption End

    • 5.5 China Glycosylated Biosimilars Market Size and Growth Rate, by Application

      • 5.5.1 China Glycosylated Biosimilars Market Size and Growth Rate of Chronic Diseases

      • 5.5.2 China Glycosylated Biosimilars Market Size and Growth Rate of Autoimmune Diseases

      • 5.5.3 China Glycosylated Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency

      • 5.5.4 China Glycosylated Biosimilars Market Size and Growth Rate of Oncology

      • 5.5.5 China Glycosylated Biosimilars Market Size and Growth Rate of Blood Disorders

      • 5.5.6 China Glycosylated Biosimilars Market Size and Growth Rate of Infectious Diseases

      • 5.5.7 China Glycosylated Biosimilars Market Size and Growth Rate of Other Diseases

    Chapter 6 China Glycosylated Biosimilars Market, by Region

    • 6.1 China Glycosylated Biosimilars Production Volume and Production Value, by Region

    • 6.2 China Glycosylated Biosimilars Sales Volume and Sales Value, by Region

    Chapter 7 North China Glycosylated Biosimilars Market Analysis

    • 7.1 North China Glycosylated Biosimilars Market, by Type

    • 7.2 North China Glycosylated Biosimilars Market, by Application

    Chapter 8 Central China Glycosylated Biosimilars Market Analysis

    • 8.1 Central China Glycosylated Biosimilars Market, by Type

    • 8.2 Central China Glycosylated Biosimilars Market, by Application

    Chapter 9 South China Glycosylated Biosimilars Market Analysis

    • 9.1 South China Glycosylated Biosimilars Market, by Type

    • 9.2 South China Glycosylated Biosimilars Market, by Application

    Chapter 10 East China Glycosylated Biosimilars Market Analysis

    • 10.1 East China Glycosylated Biosimilars Market, by Type

    • 10.2 East China Glycosylated Biosimilars Market, by Application

    Chapter 11 Northeast China Glycosylated Biosimilars Market Analysis

    • 11.1 Northeast China Glycosylated Biosimilars Market, by Type

    • 11.2 Northeast China Glycosylated Biosimilars Market, by Application

    Chapter 12 Southwest China Glycosylated Biosimilars Market Analysis

    • 12.1 Southwest China Glycosylated Biosimilars Market, by Type

    • 12.2 Southwest China Glycosylated Biosimilars Market, by Application

    Chapter 13 Northwest China Glycosylated Biosimilars Market Analysis

    • 13.1 Northwest China Glycosylated Biosimilars Market, by Type

    • 13.2 Northwest China Glycosylated Biosimilars Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Stada Arzneimittel AG

        • 14.1.1 Stada Arzneimittel AG Company Profile

        • 14.1.2 Stada Arzneimittel AG Glycosylated Biosimilars Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Dr Reddy's Laboratories

        • 14.2.1 Dr Reddy's Laboratories Company Profile

        • 14.2.2 Dr Reddy's Laboratories Glycosylated Biosimilars Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer

        • 14.3.1 Pfizer Company Profile

        • 14.3.2 Pfizer Glycosylated Biosimilars Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Amgen

        • 14.4.1 Amgen Company Profile

        • 14.4.2 Amgen Glycosylated Biosimilars Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Mylan

        • 14.5.1 Mylan Company Profile

        • 14.5.2 Mylan Glycosylated Biosimilars Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biocon

        • 14.6.1 Biocon Company Profile

        • 14.6.2 Biocon Glycosylated Biosimilars Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sandoz

        • 14.7.1 Sandoz Company Profile

        • 14.7.2 Sandoz Glycosylated Biosimilars Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Samsung Biologics

        • 14.8.1 Samsung Biologics Company Profile

        • 14.8.2 Samsung Biologics Glycosylated Biosimilars Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Celltrion

        • 14.9.1 Celltrion Company Profile

        • 14.9.2 Celltrion Glycosylated Biosimilars Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Glycosylated Biosimilars Industry Research Conclusions

    • 15.2 Glycosylated Biosimilars Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Glycosylated Biosimilars Industry Market Size (2018-2029)

    • Figure China Glycosylated Biosimilars Production Volume, Production Value and Growth Rate of EPO (2018-2029)

    • Figure China Glycosylated Biosimilars Production Volume, Production Value and Growth Rate of mAb (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Chronic Diseases (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Glycosylated Biosimilars Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

    • Figure North China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Central China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure South China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure East China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Glycosylated Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Glycosylated Biosimilars Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Glycosylated Biosimilars Market Share by Type in 2018

    • Figure China Glycosylated Biosimilars Market Share by Type in 2023

    • Figure China Glycosylated Biosimilars Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Glycosylated Biosimilars Production Volume and Growth Rate of EPO (2018-2023)

    • Figure China Glycosylated Biosimilars Production Volume and Growth Rate of mAb (2018-2023)

    • Figure China Glycosylated Biosimilars Market Share by Application in 2018

    • Figure China Glycosylated Biosimilars Market Share by Application in 2023

    • Figure China Glycosylated Biosimilars Total Market Size and Growth Rate from Consumption End

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Chronic Diseases (2018-2023)

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Autoimmune Diseases (2018-2023)

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency (2018-2023)

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Blood Disorders (2018-2023)

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Glycosylated Biosimilars Market Size and Growth Rate of Other Diseases (2018-2023)

    • Table China Glycosylated Biosimilars Production Volume by Region (2018-2023)

    • Table China Glycosylated Biosimilars Production Volume Share by Region (2018-2023)

    • Figure China Glycosylated Biosimilars Production Volume Share by Region (2018-2023)

    • Table China Glycosylated Biosimilars Production Value by Region (2018-2023)

    • Table China Glycosylated Biosimilars Production Value Share by Region (2018-2023)

    • Figure China Glycosylated Biosimilars Production Value Share by Region (2018-2023)

    • Table China Glycosylated Biosimilars Sales Volume by Region (2018-2023)

    • Table China Glycosylated Biosimilars Sales Volume Share by Region (2018-2023)

    • Figure China Glycosylated Biosimilars Sales Volume Share by Region (2018-2023)

    • Table China Glycosylated Biosimilars Sales Value by Region (2018-2023)

    • Table China Glycosylated Biosimilars Sales Value Share by Region (2018-2023)

    • Figure China Glycosylated Biosimilars Sales Value Share by Region (2018-2023)

    • Table North China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table North China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure North China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table North China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table North China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure North China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Central China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table Central China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Central China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table Central China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table Central China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Central China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table South China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table South China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure South China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table South China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table South China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure South China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table East China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table East China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure East China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table East China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table East China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure East China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northeast China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table Northeast China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northeast China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northeast China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table Northeast China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Southwest China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table Southwest China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Southwest China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table Southwest China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table Southwest China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northwest China Glycosylated Biosimilars Production Volume by Type (2018-2023)

    • Table Northwest China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northwest China Glycosylated Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northwest China Glycosylated Biosimilars Sales Volume by Application (2018-2023)

    • Table Northwest China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Glycosylated Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Stada Arzneimittel AG Company Profile

    • Table Stada Arzneimittel AG Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy's Laboratories Company Profile

    • Table Dr Reddy's Laboratories Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Sandoz Company Profile

    • Table Sandoz Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Samsung Biologics Company Profile

    • Table Samsung Biologics Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Celltrion Company Profile

    • Table Celltrion Glycosylated Biosimilars Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US